Back to trial detailsIntake questionnaire
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants
Applying to MD Anderson Cancer Center · Houston, Texas
Answer a few short questions to share with the research team.
0 of 4 answered